13.03.2014 – 14.03.2014

Veranstaltungsort: München

23. AGAH-Annual Meeting 2014

Risk mitigation in early medicines development is the focus of the 2014 Annual Meeting in Munich. Whereas recent meetings mainly addressed aspects of early clinical utility assessment and exploratory development of modern therapies, there is need for an overall evaluation of risks and in consequence for the advancement of mitigation strategies.